Expert Details
Biotechnology, Pharmaceuticals, Business Development, Technical Assessment, Business Strategy
ID: 733195
Maryland, USA
Expert is an accomplished business development executive, having completed over $300 million in transactions to date. The transactions include both in- and out-licensing and cover a range of areas including vaccines, computational chemistry, drug discovery platforms, and therapeutics.
Consulting Services:
-Licensing and transactions
-Business strategy & business plan development
-Market analysis
-Deal sourcing & technology evaluation
Profile:
• Successful business development executive: Closed >$300M in deals
• Accomplished scientist: 29 publications; leader of productive research teams
• Effective communicator: Numerous international & domestic presentations; teacher for multiple undergraduate science classes; international business mentor
Education
Year | Degree | Subject | Institution |
---|---|---|---|
Year: 1997 | Degree: Ph.D. | Subject: Cell & Molecular Biology/Biochemistry | Institution: Tulane University |
Year: 1995 | Degree: M.S | Subject: Cell & Molecular Biology/Biochemistry | Institution: Tulane University |
Year: 1993 | Degree: B.S. | Subject: Botany | Institution: Miami University |
Work History
Years | Employer | Title | Department |
---|---|---|---|
Years: 2011 to Present | Employer: Undisclosed | Title: President | Department: |
Responsibilities:One of two co-founders of a company focused on developing a proprietary molecule with broad utility for multiple vaccine and immunotherapeutic applications. Responsible for all business & corporate development and fundraising activities. |
|||
Years | Employer | Title | Department |
Years: 2014 to 2016 | Employer: Carmot Therapeutics | Title: VP of Business Development | Department: |
Responsibilities:Responsible for deals and evaluation of all business and corporate development opportunities• Led negotiations for research collaboration with Genentech (June 2016) o Upfront, FTE support, preclinical & clinical milestones, royalties on net sales • Ongoing negotiations with multiple large pharmaceutical companies • Conducted market analysis and due diligence of new market opportunities |
|||
Years | Employer | Title | Department |
Years: 2011 to Present | Employer: Undisclosed | Title: Business Mentor | Department: |
Responsibilities:• Provide business, entrepreneurial, and technical assistant and advice to Russian & Georgian (Tbilisi) researchers• Review business plans and provide recommendations for business plan competitions • Assisted in on-the-ground entrepreneurial training in Russia (St. Petersburg, May 2011) • Taught business development and scientific and technical English to Russian students and professors (St. Petersburg, June 2013) • Business Mentor for scientists and academic groups; trained university & research organizations on how to set up and run a Technology Commercialization Office; trained individual scientists on how to commercialize their scientific products |
|||
Years | Employer | Title | Department |
Years: 2011 to 2012 | Employer: Numerate | Title: VP of Business Development | Department: |
Responsibilities:• Sourced, led negotiations, and completed research collaboration with Boehringer Ingelheim for an infectious disease target (terms not disclosed)• Led negotiations and completed research collaborations with: o Merck & Co. for a cardiovascular target (terms not disclosed) o Large pharmaceutical company (undisclosed) for a CNS target o A leading epigenetics company for an oncology target (terms not disclosed) |
Government Experience
Years | Agency | Role | Description |
---|---|---|---|
Years: 1997 to 2000 | Agency: National Institutes of Health | Role: Postdoctoral & Research Fellowships | Description: Conducted advanced research and published numerous papers in virology field |
International Experience
Years | Country / Region | Summary |
---|---|---|
Years: 2005 to Present | Country / Region: Numerous | Summary: Conducted business in multiple regions throughout the world including Sweden, Russia, Republic of Georgia, Japan, Korea, Australia, Israel |